miRdetect
Bremen
About miRdetect
miRdetect creates, manufactures, and markets molecular biological tests for cancer early detection and diagnosis. The techniques created allow for the precise identification of even the tiniest amounts of nucleic acids. They supply M371 goods.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (May 2019)
- Website: mirdetect.de
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/mirdetect-2840631 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.